Therapeutics aims to improve current obesity treatment, specifically to increase overall body weight loss and fat mass loss, but preserve and even increase muscle and lean mass- Élancé Therapeutics ...

Craft Capital Management LLC acted as underwriter for the Offering (the “Underwriter”). VCL Law LLP acted as U.S. securities counsel to the Company, and Ortoli Rosenstadt LLP acted as U.S. securities ...

Greenhaven Road Capital, an investment management company, released its fourth-quarter 2024 investor letter. A copy of the ...

Advanced Biomed Inc. (the “Company” or “Advanced Biomed”), a biotechnology company focused on early screening and detection, diagnosis and staging, and treatment of cancer, today announced the pricing ...

Signs a strategic collaboration and license agreement to advance novel therapies targeting corticotropin-releasing hormone ...

This week, Advanced Biomed (ADVB) is looking to raise $112M under its initial public offering. The company is developing a portfolio of cancer screening technologies for the Chinese market.

RALEIGH, N.C., Feb. 24, 2025 /PRNewswire/ -- Kineticos Life Sciences announces the launch of Kinvard Bio, Inc., a newly established ... and Response; Biomedical Advanced Research and Development ...

Under the collaboration agreement, the parties will combine Harbour BioMed's industry-leading technology platform, proprietary dataset and extensive expertise in antibody development with Insilico's ...